Cutland CL, Peyrani P, Webber C, Newton R, et al. A phase 3, randomized, controlled, open-label study to evaluate the persistence up to 5 years of 1 or 2 doses of meningococcal conjugate vaccine MenACWY-TT given with or without 13-valent pneumococcal conjugate vaccine in 12-14-month-old children. Vaccine 2023 Jan 6:S0264-410X(22)01461-X. doi: 10.1016/j.vaccine.2022.
PMID: 36621408